Article Information
History
- February 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ivan Doykov1,
- Justyna Spiewak1,2,
- Kimberly C. Gilmour3,
- Joseph M Gibbons4,
- Corinna Pade4,
- Áine McKnight4,
- Mahdad Noursadeghi5,
- Mala K Maini5,
- Charlotte Manisty6,7,
- Thomas Treibel6,7,
- Gabriella Captur7,8,
- Marianna Fontana7,8,
- Rosemary J Boyton10,
- Daniel M Altmann11,
- Tim Brooks12,
- Amanda Semper12,
- James C Moon$,6,7,
- Kevin Mills$,1,2 and
- Wendy Heywood$,*,1,2
- 1Translational Mass Spectrometry Research Group, Genetics & Genomic Medicine Dept., UCL Institute of Child Health, London
- 2Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health London
- 3Great Ormond Street Children’s Hospital NHS Foundation Trust, Great Ormond Street, London; WC1N 3JH, UK
- 4Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
- 5Division of Infection and Immunity, University College London, London, UK
- 6St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
- 7Institute of Cardiovascular Science, University College London, London, UK
- 8Royal Free London NHS Foundation Trust; Pond Street, London NW3 2QG, UK
- 9Department of Infectious Disease, Imperial College London, London, UK
- 10Lung Division, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- 11Department of Immunology and Inflammation, Imperial College London, UK
- 12UK Health Security Agency; Porton Down, UK
- ↵*corresponding author; email: wendy.heywood{at}ucl.ac.uk
↵$ contributed equally
Posted February 15, 2022.
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
